There are many challenges which plague the process of drug discovery and development. Here we pay particular attention to the critical disconnect between early-stage development and clinical trials, and the fact that preclinical studies often fail to reliably predict clinical trial outcomes.





For many, significant hurdles still hinder widespread adoption human-specific research. Drawing from a range of insights and examples where human-focused technologies have been utilised, we address some of the common obstacles preventing the adoption of human-specific research and discuss the current state of play.